Resveratrol has been shown to attenuate angiotensin II (Ang‐II)‐induced atherosclerotic plaque formation in ApoE−/− mice; furthermore, it suppresses monocyte‐to‐macrophage differentiation and mitigates inflammation by restoring cellular glutathione (GSH) levels, thereby offering protective effects against atherosclerosis (Jing et al. 2023; Vasamsetti et al. 2016). The gene discussed is AGT; the disease is atherosclerosis.